[BCMA chimeric antigen receptor T cells therapy re-treatment of a patient with recurrent/refractory IgD multiple myeloma: A case report and literature review]. [PDF]
Gu SN, Qiang WT, Lu J, Feng ZY, Du J.
europepmc +1 more source
[Chinese expert consensus on minimal residual disease detection in multiple myeloma based on bone marrow samples (2024)]. [PDF]
Experimental Diagnostic Group +4 more
europepmc +1 more source
[Cytoplasmic light-chain immunofluorescence combined with FISH in bone marrow smears to detect cytogenetic abnormalities in multiple myeloma]. [PDF]
Shi Y +6 more
europepmc +1 more source
[Correlation analysis of polyclonal plasma cell proportion in the bone marrow with clinical characteristics of patients with newly diagnosed multiple myeloma]. [PDF]
Long XL +8 more
europepmc +1 more source
[Analysis of the efficacy and safety of bone disease treatment in patients with newly diagnosed multiple myeloma treated with denosumab or zoledronic acid]. [PDF]
Ma Y +12 more
europepmc +1 more source
[Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma]. [PDF]
Yan J, Zhou DM, Shao XY, Xu Y, Chen B.
europepmc +1 more source
[Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy]. [PDF]
Guo CC +8 more
europepmc +1 more source
[A multicenter, prospective, phaseⅡ, single-arm study on the treatment of newly diagnosed multiple myeloma with domestic bortezomib in combination with lenalidomide and dexamethasone]. [PDF]
Xie LN +12 more
europepmc +1 more source
[Retrospective clinical study on cryopreservation-free integrated autologous hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma]. [PDF]
Yang X +11 more
europepmc +1 more source

